| Literature DB >> 31771274 |
Alba García-Rodríguez1, Liliya Kazantseva1, Laura Vila1, Laura Rubio1, Antonia Velázquez1,2, María José Ramírez3, Ricard Marcos1,2, Alba Hernández1,2.
Abstract
Thousands of nanomaterials (NMs)-containing products are currently under development or incorporated in the consumer market, despite our very limited understanding of their genotoxic potential. Taking into account that the toxicity and genotoxicity of NMs strongly depend on their physicochemical characteristics, many variables must be considered in the safety evaluation of each given NM. In this scenario, the challenge is to establish high-throughput methodologies able to generate rapid and robust genotoxicity data that can be used to critically assess and/or predict the biological effects associated with those NMs being under development or already present in the market. In this study, we have evaluated the advantages of using a flow cytometry-based approach testing micronucleus (MNs) induction (FCMN assay). In the frame of the EU NANoREG project, we have tested six different NMs-namely NM100 and NM101 (TiO2NPs), NM110 (ZnONPs), NM212 (CeO2NPs), NM300K (AgNPs) and NM401 (multi-walled carbon nanotubes (MWCNTs)). The obtained results confirm the ability of AgNPs and MWCNTs to induce MN in the human bronchial epithelial BEAS-2B cell line, whereas the other tested NMs retrieved non-significant increases in the MN frequency. Based on the alignment of the results with the data reported in the literature and the performance of the FCMN assay, we strongly recommend this assay as a reference method to systematically evaluate the potential genotoxicity of NMs.Entities:
Keywords: AgNPs; BEAS-2B cells; CeO2NPs; MWCNTs; TiO2NPs; ZnONPs; flow cytometry MN (FCMN) assay
Year: 2019 PMID: 31771274 PMCID: PMC6956333 DOI: 10.3390/nano9121677
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Transmission electron microscopy (TEM) images of dried nanoparticles (NPs). TiO2NPs NM100 (A), TiO2NPs NM101 (B), ZnONPs NM110 (C), CeO2NPs NM212 (D), AgNPs NM300K (E) and multi-walled carbon nanotube (MWCNT) NM401 (F).
Nanoparticles characterization. NPs diameter analyzed by TEM in their dried forms and their hydrodynamic size, analyzed by dynamic light scattering (DLS). Data are represented as mean ± SEM.
| NP | TiO2 | TiO2 | ZnO | CeO2 | Ag | MWCNT * |
|---|---|---|---|---|---|---|
| TEM | 104.01 ± 39.42 | 54.69 ± 35.39 | 132.37 ± 69.53 | 70.33 ± 49.61 | 7.75 ± 2.48 | 6012.09 ± 4091.45 |
| DLS | 195.3 ± 2.50 | 152.2 ± 62.28 | 171.17 ± 13.61 | 172.2 ± 45.24 | 19.02 ± 1.78 | - |
* Average length.
Figure 2Viability curves tested in BEAS-2B. (A) TiO2NPs (NM100), (B) TiO2NPs (NM101), (C) ZnONPs (NM110), (D) CeO2NPs (NM212), (E) AgNPs (NM300K) and (F) MWCNTs (NM401). Results are plotted as mean ± SEM of two independent experiments. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (one way-ANOVA).
Figure 3Validation of the assay testing the ability of the flow cytometry micronucleus (FCMN) assay, using MMC as a positive control, in BEAS-2B. Data of three independent experiments are represented as mean ± SEM. *** p ≤ 0.001 (t-test).
Figure 4Micronucleus (MN) frequency (NM/1000 N) measured in BEAS-2B. (A) TiO2NPs (NM100), (B) TiO2NPs (NM101), (C) ZnONPs (NM110), (D) CeO2NPs (NM212), (E) AgNPs (NM300k) and (F) MWCNTs (NM401). Data of three independent experiments are represented as mean ± SEM. * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 (one way-ANOVA).
Comparative data summarizing the obtained results (FCMN) with the overall results obtained in the frame of the UE Nanoreg project with BEAS-2B cells in the CBMN assay.
| Nanomaterial | FCMN Assay | CBMN Assay |
|---|---|---|
| NM100 | − | − |
| NM101 | − (+ *) | − |
| NM110 | − | +/− |
| NM212 | − | nd |
| NM300K | +/− | − |
| NM401 | +/− | − |
−: negative; +: positive; +/−: weak positive; nd: no data; * results from D Bucchianico et al., 2017.